Skip to main content

Home

Phase Out of Manual Application Submission for Import and Export Licences / Certificates for Pharmaceutical Products and Dangerous Drugs with effect from 31 December 2021

Enhance Regulatory Control of Skin Antiseptic Products

Conditional Approval of Registration of Remdesivir

Special Notices on COVID-19

Regulation of Advanced Therapy Products (with effect from 1 August 2021)

Enhanced Control of Skin Antiseptics containing Chlorhexidine with effect from July 8, 2020

Requirement of Microbiological Quality of Registered Pharmaceutical Products in Non-sterile Dosage Forms

Requirement of Elemental Impurities Levels/Limits in Registered Pharmaceutical Products

Updates on the Phase 2 Requirement of Bioavailability and Bioequivalence Studies

Information on Cord Blood & Cell Therapy

New Application Form and Guidance Notes for Clinical Trial/Medicinal Test Certificate

Previous

Pause Play

Next

Press Release

Frequently Asked Question

Search Drug Dealers

Search Drug

Products found to contain undeclared medicines

Medicines Recall
Safety Alert




faq